Literature DB >> 28419594

Catheter ablation for the treatment of atrial fibrillation is associated with a reduction in health care resource utilization.

Michelle Samuel1, Meytal Avgil Tsadok1, Jacqueline Joza2, Hassan Behlouli1, Atul Verma2, Vidal Essebag2, Louise Pilote1,3.   

Abstract

BACKGROUND: Catheter ablation (CA) is superior to antiarrhythmic therapy at reducing recurrence of atrial fibrillation (AF); however, there are limited data regarding whether this decrease translates into a reduction in health care resource utilization.
OBJECTIVE: To evaluate the impact of AF ablation on long-term health care resource utilization.
METHODS: A population-based cohort was constructed to include patients who underwent CA for AF in Quebec, Canada, between April 2005 and March 2011. Resource utilization was evaluated 24 months pre- and postindex CA procedure.
RESULTS: In a cohort of 1,556 patients, resource utilization increased progressively over the 24-month period leading to index CA (P for trend <0.05 for hospitalizations, ER visits, outpatient visits, cardioversions, and echocardiograms). After index CA, all-cause hospitalizations, hospitalizations for AF, ER visits, cardioversions, and echocardiograms were reduced 12 months post-CA compared to 12 months prior (all-cause hospitalizations 0.8-0.6 per patient per year; hospitalizations for AF 0.4-0.3; ER visits 2.9-1.8; cardioversions 0.5-0.2; echocardiograms 0.8-0.5; P < 0.05 for all trends). Resource utilization continued to decline at 24 months post-CA (vs. 12 months prior) for all-cause hospitalizations (0.4), cardioversions (0.1), and echocardiograms (0.3) (per patient year; P < 0.05 for all trends).
CONCLUSION: In conclusion, the pattern of increasing health care resource utilization preceding CA for AF reverses after CA to lower than preablation levels up to 24 months post-CA.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  atrial fibrillation; catheter ablation; health care resource utilization

Mesh:

Year:  2017        PMID: 28419594     DOI: 10.1111/jce.13225

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  5 in total

1.  Long-term effectiveness of catheter ablation in patients with atrial fibrillation and heart failure.

Authors:  Michelle Samuel; Michal Abrahamowicz; Jacqueline Joza; Marie-Eve Beauchamp; Vidal Essebag; Louise Pilote
Journal:  Europace       Date:  2020-05-01       Impact factor: 5.214

2.  Multilayer fabrication of durable catheter-deployable soft robotic sensor arrays for efficient left atrial mapping.

Authors:  Varun Kashyap; Alexandre Caprio; Tejas Doshi; Sun-Joo Jang; Christopher F Liu; Bobak Mosadegh; Simon Dunham
Journal:  Sci Adv       Date:  2020-11-13       Impact factor: 14.136

3.  Population-Level Sex Differences and Predictors for Treatment With Catheter Ablation in Patients With Atrial Fibrillation and Heart Failure.

Authors:  Michelle Samuel; Michal Abrahamowicz; Jacqueline Joza; Vidal Essebag; Louise Pilote
Journal:  CJC Open       Date:  2020-02-12

4.  Catheter ablation for atrial fibrillation in heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Ahmed AlTurki; Riccardo Proietti; Ahmed Dawas; Hasan Alturki; Thao Huynh; Vidal Essebag
Journal:  BMC Cardiovasc Disord       Date:  2019-01-15       Impact factor: 2.298

Review 5.  Impact of Catheter Ablation on Quality of Life and Healthcare Utilisation.

Authors:  Sanghamitra Mohanty; Andrea Natale
Journal:  Arrhythm Electrophysiol Rev       Date:  2021-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.